Novartis, Amgen in dispute over migraine drug partnership

Swiss drugmaker Novartis AG sued Amgen Inc on Thursday, accusing the U.S. biotechnology company of trying to wrongfully back out of agreements to jointly develop and market the migraine prevention drug Aimovig and keep the profits for itself.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news